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OBJECTIVES The purpose of this research was to evaluate the impact of athletic training and, in particular,
physical deconditioning, on frequent and/or complex ventricular tachyarrhythmias assessed by
24-h ambulatory (Holter) electrocardiogram (ECG).
BACKGROUND Sudden deaths in athletes are usually mediated by ventricular tachyarrhythmias.
METHODS Twenty-four hour ambulatory ECGs were recorded at peak training and after a decondi-
tioning period of 19  6 weeks (range, 12 to 24 weeks) in a population of 70 trained athletes
selected on the basis of frequent and/or complex ventricular tachyarrhythmias (i.e., 2,000
premature ventricular depolarization [PVD] and/or 1 burst of non-sustained ventricular
tachycardia [NSVT]/24 h).
RESULTS A significant decrease in the frequency and complexity of ventricular arrhythmias was evident
after deconditioning: PVDs/24 h: 10,611  10,078 to 2,165  4,877 (80% reduction; p 
0.001) and NSVT/24 h: 6  22 to 0.5  2, (90% reduction; p  0.04). In 50 of the 70
athletes (71%), ventricular arrhythmias decreased substantially after detraining (to 500
PVDs/24 h and no NSVT). Most of these athletes with reduced arrhythmias did not have
structural cardiovascular abnormalities (37 of 50; 74%). Over the 8 4-year follow-up period,
each of the 70 athletes survived without cardiac symptoms.
CONCLUSIONS Frequent and/or complex ventricular tachyarrhythmias in trained athletes (with and without
cardiovascular abnormalities) are sensitive to brief periods of deconditioning. In athletes with
heart disease, the resolution of such arrhythmias with detraining may represent a mechanism
by which risk for sudden death is reduced. Conversely, in athletes without cardiovascular
abnormalities, reduction in frequency of ventricular tachyarrhythmias and the absence of
cardiac events in the follow-up support the benign clinical nature of these rhythm
disturbances as another expression of athlete’s heart. (J Am Coll Cardiol 2004;44:1053–8)
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oAthlete’s heart” is a complex physiologic and structural
ardiac syndrome that develops in response to intensive and
hronic athletic training. A growing body of literature has
istinguished physiologic left ventricular (LV) remodeling
ith increased LV chamber size, wall thickness, and mass
rom the pathologic form of hypertrophy characteristic of
ardiomyopathies (1–3). One of the parameters differenti-
See page 1059
ting these two forms of LV hypertrophy is regression in
avity dimension and/or wall thickness, which is confined to
athlete’s heart,” typically occurring within weeks to months
fter cessation of training (4,5).
We have reported that frequent and/or complex ventric-
lar arrhythmias occur not uncommonly in trained athletes
ith physiologic LV hypertrophy (6). However, at present,
he potential impact of deconditioning on such ventricular
From the *National Institute of Sports Medicine, Italian Olympic Committee,
ome, Italy; †San Filippo Neri Hospital, Department of Heart Disease, Rome, Italy;
nd ‡Minnneapolis Heart Institute Foundation, Minneapolis, Minnesota.
Manuscript received February 14, 2004; revised manuscript received May 13, 2004,cccepted May 18, 2004.rrhythmias in an athletic population is unresolved. There-
ore, the primary aim of this study was to assess the
elationship between physical deconditioning and the oc-
urrence of ventricular tachyarrhythmias in our unique
opulation of highly trained athletes.
ETHODS
tudy population. The case records of the Institute of
ports Science (Rome) from 1984 to 2001 were reviewed.
uring this time period, 355 athletes had been assessed by
4-h ambulatory (Holter) electrocardiogram (ECG), by
irtue of meeting the following criteria: 1) 3 premature
entricular depolarizations (PVDs) on resting 12-lead ECG
n 337), and/or 2) history of palpitations (n 18). Of the
55 athletes, 71 with particularly frequent and/or complex
entricular arrhythmias (arbitrarily defined as2,000 PVDs
nd/or 1 burst of non-sustained ventricular tachycardia
NSVT]/24 h) were initially considered for inclusion. One
thlete (2,100 PVDs and 2 bursts of NSVT on 24-h Holter
ecording) with arrhythmogenic right ventricular cardiomy-
pathy (ARVC), who died suddenly while participating in a
ompetitive field hockey game (against medical advice), was
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Ventricular Arrhythmias in Deconditioned Athletes September 1, 2004:1053–8xcluded from the study group because he did not undergo
etraining, and relevant Holter data were not obtained.
herefore, the final study group comprises 70 athletes with
requent and/or complex ventricular tachyarrhythmias on
olter ECG.
In the study subjects, 24-h Holter ECGs were initially
ecorded during periods of peak training, including a con-
itioning session (an average of 1 h in duration), similar to
hat usually performed by the athlete; the remaining time
as occupied by usual daily activities that may have involved
on-competitive and recreational physical activity.
At the time of Holter monitoring during peak training,
o athlete was taking antiarrhythmic or other cardioactive
edications. However, eight athletes (all with cardiovascu-
ar abnormalities) were taking medications at the time of the
econditioning Holter ECG, including beta-blockers (n 
), propafenone (n  2), or enalapril (n  1).
Mean age of the athletes was 25  12 years (range, 15 to
3 years); 51 subjects (72%) were male. These athletes were
ngaged in a variety of sports disciplines, most commonly
occer (n  15; 21%), basketball (n  10; 14%), and
olleyball (n  7; 10%). They also presented a broad
pectrum of athletic achievement with 25 (35%) participat-
ng at an elite level, including 18 competing in the Olympic
ames or World Championships (five finalists or medal-
sts).
ontrol group. A total of 148 athletes without structural
eart disease, of similar age (26  10 years) and gender
78% males) as the study population, with less frequent
entricular arrhythmias (100 to 2,000 PVDs/24 h and
o episode of NSVT) were assembled as a control group.
he 148 controls underwent a second Holter ECG 3 to 6
onths after the first study, and at the same level of training
without deconditioning). The time period between these
wo Holter recordings obtained during training (19  4
eeks; range, 12 to 24 weeks) was the same as between the
ctive and deconditioned phases in the 70 athletes with
requent and/or complex ventricular tachyarrhythmias.
chocardiography. Echocardiographic studies were per-
ormed using Hewlett-Packard 77020 AC or Sonos 5500
Andover, Massachusetts). Images of the heart were ob-
ained in multiple cross-sectional planes using standard
ransducer positions. The LV cavity dimensions, anterior
entricular septal and posterior free wall thicknesses, and
eft atrial dimension were obtained from M-mode echocar-
iograms in accordance with previous recommendations (7).
o enhance the accuracy of LV wall thickness measure-
Abbreviations and Acronyms
ARVC arrhythmogenic right ventricular
cardiomyopathy
LV  left ventricle/ventricular
NSVT  non-sustained ventricular tachycardia
PVD  premature ventricular depolarizationents, these dimensions were verified from two- oimensional images (1); LV ejection fraction was measured
rom end-diastolic and end-systolic volumes in the apical
our-chamber view.
Left ventricular mass was calculated by the formula of
evereux (8) and normalized to body surface area. Param-
ters of LV filling were obtained with pulsed Doppler
chocardiography (9).
iagnostic criteria. ARVC. Echocardiographic criteria
sed for the clinical diagnosis of ARVC included right
entricular cavity dilation and/or segmental thinning, bulg-
ng or aneurysm formation, and wall motion abnormalities,
s suggested by the Task Force of the European Society of
ardiology and Federation of Cardiology (10).
yocarditis. Diagnosis of myocarditis was based on labo-
atory evidence of an inflammatory condition involving
yocardium, associated either with segmental LV wall
otion abnormalities and cavity enlargement, and con-
rmed in selected cases (n  4) by biopsy showing histo-
athology in accord with the Dallas criteria (11).
ilated cardiomyopathy. Dilated cardiomyopathy was di-
gnosed based on marked LV cavity dilation (end-diastolic
imension 60 mm) associated with systolic LV dysfunc-
ion (ejection fraction50%) and/or segmental wall motion
bnormalities, and differentiated from physiologic cavity
nlargement as previously reported (3,12).
itral valve prolapse. Mitral valve prolapse was identified
y evidence of elongated, thickened, and redundant leaflets
illowing beyond the mitral annulus plane during systole, in
he parasternal long-axis echocardiographic view (13).
econditioning. Based on the Italian guidelines for deter-
ining eligibility in competitive athletes with cardiovascular
bnormalities (14) (which closely resemble those of the 26th
ethesda Conference) (15), each of the 70 athletes with
requent and/or complex ventricular tachyarrhythmias was
isqualified from competitive sports.
The 70 athletes underwent a deconditioning period of at
east three consecutive months (mean, 19  6 weeks; range,
2 to 24 weeks). This time period was selected because it
as been shown to be sufficient to reverse the cardiac
emodeling induced by physical training (5). After decon-
itioning, each athlete had a second cardiovascular assess-
ent, which also included a 24-h Holter ECG performed
nder the same conditions as at peak training, except for
ight athletes who were receiving pharmacologic treatment
ith propafenone, sotalol, or enalapril at the time of the
ost recent Holter. This second 24-h Holter ECG also
ncluded a conditioning session similar to that usually
erformed by the athlete (of about 1 h in duration).
Ventricular tachyarrhythmias were regarded as having
artial reversibility when PVDs decreased to 500
VDs/24 h (in the absence of NSVT) on the second Holter
CG. Arrhythmias were considered to show complete
eversibility when PVDs and NSVT decreased to 0/24 h.
lectrophysiologic study. Of these 70 athletes, 24 were
elected on clinical and Holter indications for electrophysi-
logic study: 10,000 PVDs/24 h (n  10), 10,000
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September 1, 2004:1053–8 Ventricular Arrhythmias in Deconditioned AthletesVDs and NSVT (n  9), or 2,000 PVDs and NSVT
n  5). Ventricular stimulation was performed using a
rogrammable stimulator (Medtronic 5328, Medtronic
nc., Minneapolis, Minnesota), delivering rectangular pulses
f 2 ms duration at twice the diastolic threshold. Up to three
xtrastimuli were introduced after eight ventricular paced
eats at three drive cycle lengths (600, 500, and 400 ms) and
n two right ventricular sites (apex and outflow tract).
rogrammed stimulation during isoproterenol infusion was
ubsequently performed in athletes who otherwise were not
nducible.
tatistics. Data are expressed as mean  SD. Differences
etween means were assessed by unpaired or paired Student
test, where appropriate. A two-tailed p value of0.05 was
onsidered statistically significant.
ESULTS
entricular tachyarrhythmias at peak conditioning and
fter deconditioning. PEAK CONDITIONING. Frequency of
VDs on 24-h Holter ECG performed during the period of
eak training and competition ranged from 2,089 to 43,151
mean, 10,611  10,078), including 21 athletes (34%) with
10,000 PVDs. Each of the 70 athletes had 1 couplet
mean, 48  131; range, 1 to 280); 37 athletes (53%) also
ad 1 to 179 bursts of NSVT (mean, 6) consisting of 3 to 28
onsecutive beats at heart rates of 130 to 270 beats/min. Of
he 70 athletes, 8 (11%) reported frequent or prolonged
alpitations (each with10,000 PVDs or NSVT), but none
ad episodes of impaired consciousness or other cardiac
ymptoms.
ECONDITIONING. After the deconditioning period, the
verall study group showed significant reduction in PVDs,
ouplets, and NSVT; PVDs decreased from 10,611 
0,078 to 2,165  4,877 (80% reduction; p  0.001);
ouplets from 48  131 to 9  45 (80% reduction; p 
.02); and NSVT from 6  22 to 0.5  2 (90% reduction;
 0.038) (Fig. 1).
Individual subject analysis showed that after decondition-
ng, 50 of 70 athletes (71%) showed partial or complete
igure 1. Number of premature ventricular depolarizations (PVD), ventricu
4-h Holter electrocardiogram recording at peak training and after the peeversibility of ventricular arrhythmias. Partial reversal of pentricular tachyarrhythmias (i.e., to 500 PVDs and
bsence of NSVT/24 h) was evident in 34 athletes; com-
lete abolition of arrhythmias (no PVDs and NSVT/24 h)
ccurred in 16 athletes (Figs. 2 and 3). In the remaining 20
thletes (29%), frequency of ventricular arrhythmias showed
o significant reduction in frequency after detraining (i.e.,
ersistence of500 PVDs/24 h), including 6 in whom runs
f NSVT persisted. No athlete showed an increase of
entricular arrhythmias after deconditioning.
entricular tachyarrhythmias in the control group. Con-
rol group athletes did not show significant variability in
entricular arrhythmias between the two Holter ECGs ob-
ained during training (19 4 weeks interval training period).
or example, mean number of PVDs on the first Holter was
,211  850 and on the second was 1,050  648 (p  NS)
Table 1).
elation of change in ventricular tachyarrhythmias with
econditioning to cardiovascular abnormalities. Of the
0 athletes who showed reversibility of ventricular arrhyth-
ias after deconditioning, most (37; 74%) had no cardio-
ascular abnormalities, and 13 (26%) had cardiac abnormal-
ties, including mitral valve prolapse (n  5), myocarditis (n
3), dilated cardiomyopathy (n  3), and ARVC (n  2).
uplets, and bursts of non-sustained ventricular tachycardia (NSVT) during
f deconditioning in 70 trained athletes.
igure 2. Effect of deconditioning on frequent and/or complex ventricular
achyarrhythmias in 70 trained athletes. C-V abn.  cardiovascular
bnormalities; NSVT  non-sustained ventricular tachycardia; PVDs lar co
riod oremature ventricular depolarizations.
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Ventricular Arrhythmias in Deconditioned Athletes September 1, 2004:1053–8n particular, each of the 16 athletes who showed complete
eversibility of ventricular arrhythmias after detraining had
o cardiovascular abnormalities.
In the remaining 20 athletes for whom ventricular ar-
hythmias remained substantially unchanged after detrain-
ng, 13 had no cardiovascular abnormalities (65%), and 7
35%) had either ARVC (n 4), mitral valve prolapse (n
), myocarditis (n  1), or dilated cardiomyopathy (n  1)
Fig. 2). Therefore, the absence of structural heart disease
as similar in athletes with or without reversibility of
entricular arrhythmias after deconditioning (37/50; 74% vs.
3/20; 65%; p  NS).
elation of change in ventricular tachyarrhythmias with
econditioning to LV mass. During peak training, LV
ass index was 115  24 g/m2 (range, 77 to 170 g/m2) and
fter deconditioning decreased to 93  20 g/m2 (range, 53
o 140 g/m2). The decrease in LV mass after detraining did
ot differ between athletes who experienced partial or
omplete reversibility of ventricular arrhythmias with de-
onditioning and athletes with no change in arrhythmias
116  22 g/m2 to 94  18 g/m2; 19% reduction vs. 114 
2 g/m2 to 93  26 g/m2; 18% reduction; p  NS).
igure 3. Arrhythmia trends during 24-h Holter electrocardiogram
ECG) recordings showing marked reversibility of premature ventricular
epolarizations (PVDs) after three months of deconditioning in a 32-year-
ld elite bobsledder. (Top panel) The 24-h ECG performed during peak
raining shows 3,288 PVDs, distributed relatively homogeneously, with a
light reduction evident during the evening hours. (Bottom panel) Marked
eduction in ventricular arrhythmias (to 73 PVDs) is evident after three
onths of physical deconditioning. The reduction of ventricular arrhyth-
ia after detraining has occurred throughout the 24-h recording period.
able 1. 24-H Holter Monitoring Electrocardiographic
ecordings in 148 Control Group Athletes
First 24-H
Holter (Training)
Second 24-H
Holter (Training) P Value
VDs (range) 100–1,890 88–1,750 NS
VDs (mean) 1,211  850 1,050  648 NS
o. of athletes
with couplet
8 (5%) 6 (4%) NS
o. of athletes
with NSVT
0 0 NS
SVT  non-sustained ventricular tachycardia; PVD  premature ventricular
depolarization.elation of change in ventricular tachyarrhythmias to
lectrophysiologic findings. Of the 24 athletes who un-
erwent electrophysiologic study, 23 (10 with and 13
ithout cardiovascular abnormalities) showed no ventricular
rrhythmias or only non-sustained runs of ventricular tachy-
ardia during programmed ventricular stimulation; most of
hese 23 athletes (17; 74%) had shown reduced arrhythmia
requency after deconditioning (i.e., 4,376  754 to 336 
12 PVDs/24 h).
Only one athlete, a 32-year-old cyclist with ARVC and
2,000 PVDs and 5 NSVT bursts on Holter ECG, had
nduced sustained ventricular tachycardia (by two extra-
timuli); oral administration of sotalol reduced ventricular
rrhythmias (to 500 PVDs and absence of NSVT).
ollow-up. The 70 study athletes and the 148 controls
ere periodically examined at our institute over 8  4 years
fter identification of ventricular tachyarrhythmias. Over
his follow-up period, each of the 70 athletes and each of the
48 controls survived without experiencing cardiac symp-
oms or events. The 37 of the 70 athletes with partial or
omplete reversibility of the ventricular tachyarrhythmias
fter deconditioning (and without cardiovascular abnormal-
ties) resumed competitive sports without restriction. In
ddition, six athletes with cardiovascular abnormalities
three with mitral valve prolapse and without significant
egurgitation, and three with healed myocarditis), who had
hown partial and substantial reduction of ventricular ar-
hythmias after deconditioning, were also allowed to resume
ompetitive activity.
The remaining 27 of the 70 athletes were permanently
isqualified because of structural cardiovascular diseases
uch as dilated cardiomyopathy or ARVC, and/or frequent,
nd/or complex ventricular arrhythmias, which were not
eversible after deconditioning (either in the presence or
bsence of cardiovascular abnormalities).
harmacologic treatment. Pharmacologic treatment, with
eta-blocker or propafenone at the time of the first Holter
CG, did not influence reversibility of ventricular tachyar-
hythmias with deconditioning. The proportion of athletes
ith partial or complete reversal of ventricular arrhythmias
as similar in those taking cardioactive drugs (5 of 8; 63%)
s in those without medications (42 of 62; 70%; p  NS).
ISCUSSION
e have previously shown that intense athletic condition-
ng may be associated with the occurrence of frequent
nd/or complex ventricular tachyarrhythmias on ambulatory
Holter) ECG (6). These observations are extended in the
resent study where we demonstrate that detraining can
everse this process, whether or not structural cardiovascular
bnormalities are present. Indeed, frequent and/or complex
entricular tachyarrhythmias in 70 highly trained and elite
thletes were particularly sensitive to short periods of
econditioning (19 weeks on average), including complete
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September 1, 2004:1053–8 Ventricular Arrhythmias in Deconditioned Athleteseversibility in about one-fourth and partial reversibility in
lmost one-half.
The mechanisms that explain reduction in ventricular
achyarrhythmias with deconditioning are probably com-
lex, but likely are related to autonomic nervous system
hanges associated with high-intensity training and detrain-
ng. Intensive endurance training has been shown to shift
utonomic modulation from parasympathetic to sympa-
hetic predominance (16), which may predispose to an
lectrical instability of the ventricles and eventually trigger
entricular tachyarrhythmias (17). Alternatively, sinus bra-
ycardia, characteristic of athlete’s heart (with lengthening
f the R-R interval) could facilitate the emergence of PVDs
18,19). The increase in cardiac mass induced by training is
n unlikely explanation for the ventricular tachyarrhythmias
n our athletes, given the mild degree of cardiac remodeling
resent in our study group, and the observation that
ecreased cardiac dimensions after deconditioning was sim-
lar in athletes with and without reversible ventricular
rrhythmias. The possibility of significant spontaneous vari-
bility of ventricular arrhythmias in our study group is
nlikely, given the lack of arrhythmia variation documented
n the control group of trained athletes.
The removal of athletes with cardiovascular disease (such
s hypertrophic cardiomyopathy) from intense training and
ompetition has been promoted as a strategy to reduce the
isk for sudden death (14,15,20,21). Recently, Corrado et al.
22) showed that the risk for sudden death in young
ompetitive athletes with cardiovascular disease was 2.5-fold
reater than in non-athletes. These data suggest that sports
ctivity itself may act as a trigger for life-threatening
entricular tachyarrhythmias during intense physical exer-
ion in susceptible individuals with silent cardiovascular
iseases, thereby predisposing to cardiac arrest. Based on
ur present data, in which no athlete (with or without
ardiovascular abnormalities) experienced a clinical event or
udden death during follow-up after deconditioning, we
ropose that such a favorable outcome may be related to the
eduction in ventricular arrhythmias associated with de-
raining. Therefore, the deconditioning effect on arrhyth-
ias is a potential mechanism by which disqualification
rom intense competitive sports may reduce the risk for
udden cardiac death in those athletes with structural heart
isease and frequent and/or complex ventricular arrhyth-
ias. Our data support, therefore, the restriction from
ompetitive sports in athletes with frequent and/or complex
entricular tachyarrhythmias and structural heart disease, as
uggested by the present recommendations (14,15,20).
onversely, this study also identified a subset of athletes
ithout cardiovascular abnormalities, and with reversibility
f ventricular arrhythmias, who resumed training and com-
etition and experienced a benign course. Therefore, reso-
ution of ventricular tachyarrhythmias with deconditioning
ay justify resumption of competition without risk in these
thletes without heart disease.
However, some caution is suggested in interpreting our data in the context of certain clinical circumstances. For
xample, we cannot exclude the possibility that in an
ccasional athlete the observed reduction in ventricular
rrhythmias was due to the resolution of previously unrec-
gnized structural heart disease (such as myocarditis), rather
han to a deconditioning effect. Nevertheless, given the large
umber of trained athletes with ventricular tachyarrhyth-
ias in our cohort (and the rarity of cardiovascular abnor-
alities in a young athletic population) (23), this explana-
ion seems very unlikely for the vast majority of athletes in
he present analysis.
Recommendations for the eligibility of athletes without
ardiovascular disease or abnormalities, but with frequent
nd/or complex ventricular tachyarrhythmias on ambulatory
olter ECG, are presently unresolved and have not yet been
efinitively addressed in formal expert consensus panels
uch as the Bethesda Conference (15) or the Italian guide-
ines (14). However, it is our current practice to initially
ithdraw such athletes from all training and competition for
hree to six months and then reevaluate with ambulatory
olter ECG monitoring for the presence of these arrhyth-
ias. If ventricular tachyarrhythmias are greatly reduced in
requency or abolished at the end of the detraining period,
hen competitive sports participation can be resumed. Close
ollow-up of athletes with frequent and/or complex ventric-
lar arrhythmias is recommended for the assessment of new
ymptoms, and/or to detect worsening of arrhythmias, or
he possible expression of a previously undiagnosed cardio-
ascular abnormality with late clinical onset (24). On the
ther hand, no limitation in sports activity is recommended
or athletes without cardiovascular abnormalities and less
requent arrhythmias (such as in the 148 control group
thletes), due to their favorable prognosis and the observa-
ion that sports training and competition were not associ-
ted with an increase in arrhythmia frequency.
In those athletes with underlying cardiovascular disease or
bnormalities, and with frequent and/or complex ventricular
achyarrhythmias, permanent (or temporary in selected
ases) disqualification from most competitive sports is indi-
ated. These guidelines are based primarily on recommen-
ations for the athlete’s particular structural heart disease
i.e., hypertrophic cardiomyopathy, ARVC, dilated cardio-
yopathy, or myocarditis) (23). With particular regard to
itral valve prolapse, exertion-related sudden cardiac death
s a known, albeit uncommon, consequence, particularly in
hose athletes with frequent and/or complex ventricular
rrhythmias (23). Therefore, it is prudent to disqualify from
ompetitive sports athletes with mitral valve prolapse asso-
iated with frequent and/or complex ventricular arrhythmias
15,23).
In conclusion, frequent and/or complex ventricular tachy-
rrhythmias in highly trained athletes are sensitive to short
eriods of deconditioning. This reversibility of arrhythmias
fter deconditioning was observed both in athletes with and
ithout cardiovascular abnormalities. In athletes with heart
isease, resolution of arrhythmias after detraining could
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Ventricular Arrhythmias in Deconditioned Athletes September 1, 2004:1053–8xplain the mechanism by which the restriction of these
thletes from intense sports competition may reduce their
isk for sudden death. Conversely, in athletes without
ardiovascular abnormalities, the reversibility of ventricular
achyarrhythmias (and the absence of cardiac events in the
ollow-up period) support the benign clinical nature of these
rrhythmias as another expression of athlete’s heart.
eprint requests and correspondence: Dr. Alessandro Biffi,
ational Institute of Sports Medicine, Italian Olympic Commit-
ee, Via dei Campi Sportivi, 46, 00197 - Rome, Italy. E-mail:
.biffi@libero.it.
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